Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 115

1.

The breadth and potency of passively acquired human immunodeficiency virus type 1-specific neutralizing antibodies do not correlate with the risk of infant infection.

Lynch JB, Nduati R, Blish CA, Richardson BA, Mabuka JM, Jalalian-Lechak Z, John-Stewart G, Overbaugh J.

J Virol. 2011 Jun;85(11):5252-61. doi: 10.1128/JVI.02216-10. Epub 2011 Mar 16.

PMID:
21411521
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

The breadth and titer of maternal HIV-1-specific heterologous neutralizing antibodies are not associated with a lower rate of mother-to-child transmission of HIV-1.

Chaillon A, Wack T, Braibant M, Mandelbrot L, Blanche S, Warszawski J, Barin F.

J Virol. 2012 Oct;86(19):10540-6. doi: 10.1128/JVI.00518-12. Epub 2012 Jul 18.

PMID:
22811522
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

HIV-1 maternal and infant variants show similar sensitivity to broadly neutralizing antibodies, but sensitivity varies by subtype.

Mabuka J, Goo L, Omenda MM, Nduati R, Overbaugh J.

AIDS. 2013 Jun 19;27(10):1535-44. doi: 10.1097/QAD.0b013e32835faba5.

PMID:
23856624
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

The role of neutralizing antibodies in prevention of HIV-1 infection: what can we learn from the mother-to-child transmission context?

Braibant M, Barin F.

Retrovirology. 2013 Oct 7;10:103. doi: 10.1186/1742-4690-10-103. Review.

PMID:
24099103
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Short communication: HIV type 1 subtype C variants transmitted through the bottleneck of breastfeeding are sensitive to new generation broadly neutralizing antibodies directed against quaternary and CD4-binding site epitopes.

Russell ES, Ojeda S, Fouda GG, Meshnick SR, Montefiori D, Permar SR, Swanstrom R.

AIDS Res Hum Retroviruses. 2013 Mar;29(3):511-5. doi: 10.1089/AID.2012.0197. Epub 2013 Jan 18.

PMID:
23075434
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Evidence for efficient vertical transfer of maternal HIV-1 envelope-specific neutralizing antibodies but no association of such antibodies with reduced infant infection.

Omenda MM, Milligan C, Odem-Davis K, Nduati R, Richardson BA, Lynch J, John-Stewart G, Overbaugh J.

J Acquir Immune Defic Syndr. 2013 Oct 1;64(2):163-6. doi: 10.1097/QAI.0b013e31829f6e41.

PMID:
23774880
[PubMed - indexed for MEDLINE]
7.

Passively transmitted gp41 antibodies in babies born from HIV-1 subtype C-seropositive women: correlation between fine specificity and protection.

Diomede L, Nyoka S, Pastori C, Scotti L, Zambon A, Sherman G, Gray CM, Sarzotti-Kelsoe M, Lopalco L.

J Virol. 2012 Apr;86(8):4129-38. doi: 10.1128/JVI.06359-11. Epub 2012 Feb 1.

PMID:
22301151
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

The genetic bottleneck in vertical transmission of subtype C HIV-1 is not driven by selection of especially neutralization-resistant virus from the maternal viral population.

Russell ES, Kwiek JJ, Keys J, Barton K, Mwapasa V, Montefiori DC, Meshnick SR, Swanstrom R.

J Virol. 2011 Aug;85(16):8253-62. doi: 10.1128/JVI.00197-11. Epub 2011 May 18.

PMID:
21593171
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Profiles of neutralizing antibody response in chronically human immunodeficiency virus type 1 clade B'-infected former plasma donors from China naive to antiretroviral therapy.

Hu X, Hong K, Zhao C, Zheng Y, Ma L, Ruan Y, Gao H, Greene K, Sarzotti-Kelsoe M, Montefiori DC, Shao Y.

J Gen Virol. 2012 Oct;93(Pt 10):2267-78. doi: 10.1099/vir.0.043802-0. Epub 2012 Jul 12.

PMID:
22791603
[PubMed - indexed for MEDLINE]
Free Article
10.

High titer HIV-1 V3-specific antibodies with broad reactivity but low neutralizing potency in acute infection and following vaccination.

Davis KL, Gray ES, Moore PL, Decker JM, Salomon A, Montefiori DC, Graham BS, Keefer MC, Pinter A, Morris L, Hahn BH, Shaw GM.

Virology. 2009 May 10;387(2):414-26. doi: 10.1016/j.virol.2009.02.022. Epub 2009 Mar 18.

PMID:
19298995
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

HIV-specific antibodies capable of ADCC are common in breastmilk and are associated with reduced risk of transmission in women with high viral loads.

Mabuka J, Nduati R, Odem-Davis K, Peterson D, Overbaugh J.

PLoS Pathog. 2012;8(6):e1002739. doi: 10.1371/journal.ppat.1002739. Epub 2012 Jun 14.

PMID:
22719248
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Epitopes for broad and potent neutralizing antibody responses during chronic infection with human immunodeficiency virus type 1.

Nandi A, Lavine CL, Wang P, Lipchina I, Goepfert PA, Shaw GM, Tomaras GD, Montefiori DC, Haynes BF, Easterbrook P, Robinson JE, Sodroski JG, Yang X; NIAID Center for HIV/AIDS Vaccine Immunology.

Virology. 2010 Jan 20;396(2):339-48. doi: 10.1016/j.virol.2009.10.044. Epub 2009 Nov 17.

PMID:
19922969
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Coverage of primary mother-to-child HIV transmission isolates by second-generation broadly neutralizing antibodies.

Nakamura KJ, Cerini C, Sobrera ER, Heath L, Sinkala M, Kankasa C, Thea DM, Mullins JI, Kuhn L, Aldrovandi GM.

AIDS. 2013 Jan 28;27(3):337-46. doi: 10.1097/QAD.0b013e32835cadd6.

PMID:
23296195
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Human immunodeficiency virus type 1 superinfection occurs despite relatively robust neutralizing antibody responses.

Blish CA, Dogan OC, Derby NR, Nguyen MA, Chohan B, Richardson BA, Overbaugh J.

J Virol. 2008 Dec;82(24):12094-103. doi: 10.1128/JVI.01730-08. Epub 2008 Oct 8.

PMID:
18842728
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Transmission of HIV-1 in the face of neutralizing antibodies.

Blish CA, Blay WM, Haigwood NL, Overbaugh J.

Curr HIV Res. 2007 Nov;5(6):578-87. Review.

PMID:
18045114
[PubMed - indexed for MEDLINE]
16.

Use of silver nanoparticles increased inhibition of cell-associated HIV-1 infection by neutralizing antibodies developed against HIV-1 envelope proteins.

Lara HH, Ixtepan-Turrent L, Garza TreviƱo EN, Singh DK.

J Nanobiotechnology. 2011 Sep 18;9:38. doi: 10.1186/1477-3155-9-38.

PMID:
21923937
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

The Antibody Response against HIV-1.

Overbaugh J, Morris L.

Cold Spring Harb Perspect Med. 2012 Jan;2(1):a007039. doi: 10.1101/cshperspect.a007039. Review.

PMID:
22315717
[PubMed - indexed for MEDLINE]
Free PMC Article
18.
19.

Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies.

Seaman MS, Janes H, Hawkins N, Grandpre LE, Devoy C, Giri A, Coffey RT, Harris L, Wood B, Daniels MG, Bhattacharya T, Lapedes A, Polonis VR, McCutchan FE, Gilbert PB, Self SG, Korber BT, Montefiori DC, Mascola JR.

J Virol. 2010 Feb;84(3):1439-52. doi: 10.1128/JVI.02108-09. Epub 2009 Nov 25.

PMID:
19939925
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Antibody responses elicited in macaques immunized with human immunodeficiency virus type 1 (HIV-1) SF162-derived gp140 envelope immunogens: comparison with those elicited during homologous simian/human immunodeficiency virus SHIVSF162P4 and heterologous HIV-1 infection.

Derby NR, Kraft Z, Kan E, Crooks ET, Barnett SW, Srivastava IK, Binley JM, Stamatatos L.

J Virol. 2006 Sep;80(17):8745-62. Erratum in: J Virol. 2007 Feb;81(3):1538.

PMID:
16912322
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk